March 20, 2015
AADA briefs FTC on mounting burdens facing dermatology
In an exclusive meeting with the AADA, the Federal Trade Commission (FTC) and the United States Department of Justice, Antitrust Division heard concerns facing dermatologists in light of a new era of payment reform. As public and private payers move out of fee-for-service models, dermatologists who practice in small or solo offices need increased flexibility for alternative payment models in order to keep their doors open to patients – particularly in rural and community settings. The AADA encouraged the FTC to analyze how competition for small and solo practices would be affected under models of care. The FTC heard first-hand from the AADA physician leaders about the work underway to identify a value-based approach to dermatologic payment systems.
The FTC also heard the AADA’s concerns about narrowing networks – and the predatory practices of insurance companies to eliminate patient choice in selecting a provider. The AADA successfully advocated for network adequacy requirements for health plans offered through the state exchanges, but Medicare Advantage plans have yet to formally adopt similar requirements.
The meeting with FTC comes on the heels of a public workshop – held last month – in which the agency convened stakeholders to examine how these issues affect health care competition. As the AADA explores new payment models and continues to fight for network adequacy, it will continue to engage the FTC on any downstream affects to dermatology practices.
More advocacy highlights:
- Congress introduces bipartisan bill to end 13-year SGR rollercoaster
- UHC dermatopathology pilot program undermines physician expertise
- AADA calls for physician notification for biosimilars substitution
- House doctors caucus fights to keep global codes
View full issue.